FERROFLUID FOR RADIOFREQUENCY CAPACITIVE HYPERTHERMIA: IN-VITRO STUDY

1 KAZANTSEVA Natalia E.
Co-authors:
1 HUMPOLICEK Petr 1 MOUCKA Robert 1 VILCAKOVA Jarmila 1 SMOLKOVA Ilona S. 1 SAHA Petr
Institution:
1 Centre of Polymer Systems, Tomas Bata University in Zlin, Trida Tomase Bati 5678, 760 01 Zlin, Czech Republic, EU, kazantseva@cps.utb.cz
Conference:
8th International Conference on Nanomaterials - Research & Application, Hotel Voronez I, Brno, Czech Republic, EU, October 19th - 21st 2016
Proceedings:
Proceedings 8th International Conference on Nanomaterials - Research & Application
Pages:
449-454
ISBN:
978-80-87294-71-0
ISSN:
2694-930X
Published:
17th March 2017
Proceedings of the conference were published in Web of Science and Scopus.
Metrics:
63 views / 22 downloads
Abstract

The current work deals with preparation and characterization of electrically lossy ferrofluid which can be used as a mediator for radio frequency (RF) - capacitive hyperthermia method. To this end, ferrofluid that can absorb the energy of alternating electrical field at the frequencies commonly employed in RF-capacitive hyperthermia (13.56 and 27.12 MHz) has been prepared by co-precipitation method. This ferrofluid comprises of electrically conductive component with core-shell structure, i.e. magnetite nanoparticles (NPs) coated by dextran, organized in chain-like structure. The effect of RF – capacitive hyperthermia in the presence of mediator was studied on the series of tests performed on HaCaT and HepG2 cell lines using MMT test. The RF-electrical field (13.56 MHz) with controllable power output was applied using the EHY-110 SA (Oncotherm group) to increase the temperature of samples from 37 °C up to target temperature of 44 °C. The results of in-vitro test clearly indicate that the usage of capacitive heating of obtained ferrofluid substantially contribute to cytotoxic effect of hyperthermia treatment.

Keywords: Iron oxide nanoparticles; Dextran; Core - shell nanoparticles; Hyperthermia

© This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Scroll to Top